Verquvo
Generic name: Vericiguat
Drug class:
Vasodilators
Usage of Verquvo
Verquvo is a soluble guanylate cyclase stimulator (sGC). Stimuating sGC, an enzyme involved in controlling heart muscle, results in smooth muscle relaxation and widening of blood vessels.
Verquvo is a prescription medicine used in adults who have been in hospital recently or need to receive intravenous (IV) medicines and have an ejection fraction (amount of blood pumped with each heartbeat) of less than 45 percent who have chronic heart failure. Verquvo lowers the risk of death or needing to be in the hospital.
Heart failure happens when your heart is weak and cannot pump enough blood to your lungs and the rest of your body. It is not known if Verquvo is safe and effective in children.
Verquvo side effects
Get emergency medical help if you have signs of an allergic reaction to Verquvo: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
Common Verquvo side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Verquvo
You should not use Verquvo if you are also using a similar medicine called riociguat.
Do not use Verquvo if you are pregnant. It could harm the unborn baby or cause birth defects. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 1 month after your treatment ends. Tell your doctor right away if you miss a menstrual period or think you may have become pregnant during treatment.
You will need to have a negative pregnancy test before starting this treatment.
You should not breastfeed while using Verquvo.
Relate drugs
- Adempas
- Apresoline
- Apresoline (Hydralazine Injection)
- Apresoline (Hydralazine Oral)
- Hydralazine
- Hydralazine (Injection)
- Hydralazine (Oral)
- Loniten
- Minoxidil
- Minoxidil (Oral)
- Natrecor
- Nesiritide
- Novaplus HydrALAZINE Hydrochloride
- Riociguat
- Vericiguat
- Verquvo
How to use Verquvo
Usual Adult Dose for Heart Failure:
Initial dose: 2.5 mg orally once daily with food Maintenance dose: Double the dose every 2 weeks to reach the maintenance target dose of 10 mg daily as tolerated. Comments: -Tablets may be crushed and mixed with water if the patient has difficulty swallowing. Use: To reduce the risk of cardiovascular death and heart failure (HF) hospitalization following a hospitalization for HF or need for outpatient IV diuretics, in adults with symptomatic chronic HF and ejection fraction less than 45%.
Warnings
You should not use Verquvo if you are also using riociguat.
Vericiguat can cause birth defects. Do not use if you are pregnant. Use effective birth control while taking Verquvo and for at least 1 month after your last dose. Do not have unprotected sex.
What other drugs will affect Verquvo
Tell your doctor about all your other medicines, especially:
This list is not complete. Other drugs may interact with vericiguat, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions